$MYOK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MyoKardia, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MyoKardia, Inc.. Get notifications about new insider transactions in MyoKardia, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 08 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 77,949 | 74.9 K to 77.9 K (+4.00 %) |
Jul 25 2018 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Option Exercise | M | 13.90 | 7,500 | 104,250 | 7,500 | |
Jul 25 2018 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Sell | S | 57.28 | 3,101 | 177,625 | 60,606 | 63.7 K to 60.6 K (-4.87 %) |
Jul 25 2018 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Sell | S | 56.59 | 4,399 | 248,939 | 63,707 | 68.1 K to 63.7 K (-6.46 %) |
Jul 25 2018 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Buy | M | 13.90 | 7,500 | 104,250 | 68,106 | 60.6 K to 68.1 K (+12.38 %) |
Jul 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 117,254 | |
Jul 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 54.30 | 100 | 5,430 | 74,949 | 75 K to 74.9 K (-0.13 %) |
Jul 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 53.32 | 2,400 | 127,974 | 75,049 | 77.4 K to 75 K (-3.10 %) |
Jul 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 51.95 | 500 | 25,975 | 77,449 | 77.9 K to 77.4 K (-0.64 %) |
Jul 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 77,949 | 74.9 K to 77.9 K (+4.00 %) |
Jul 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 117,254 | |
Jul 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 54.30 | 100 | 5,430 | 74,949 | 75 K to 74.9 K (-0.13 %) |
Jul 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 53.32 | 2,400 | 127,974 | 75,049 | 77.4 K to 75 K (-3.10 %) |
Jul 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 51.95 | 500 | 25,975 | 77,449 | 77.9 K to 77.4 K (-0.64 %) |
Jul 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 77,949 | 74.9 K to 77.9 K (+4.00 %) |
Jun 29 2018 | MYOK | MyoKardia Inc | Semigran Marc | Chief Medical Offic ... | Option Exercise | A | 15.95 | 6,250 | 99,688 | 6,250 | |
Jun 29 2018 | MYOK | MyoKardia Inc | Lee June | See Remarks | Option Exercise | A | 11.95 | 6,250 | 74,688 | 6,250 | |
Jun 14 2018 | MYOK | MyoKardia Inc | Meeker David P | Director | Option Exercise | A | 48.85 | 11,000 | 537,350 | 11,000 | |
Jun 14 2018 | MYOK | MyoKardia Inc | CRANSTON MARY B | Director | Option Exercise | A | 48.85 | 11,000 | 537,350 | 11,000 | |
Jun 14 2018 | MYOK | MyoKardia Inc | Popovits Kimberly J | Director | Option Exercise | A | 48.85 | 11,000 | 537,350 | 11,000 | |
Jun 14 2018 | MYOK | MyoKardia Inc | AGARWAL SUNIL | Director | Option Exercise | A | 48.85 | 11,000 | 537,350 | 11,000 | |
Jun 14 2018 | MYOK | MyoKardia Inc | PERRY MARK L | Director | Option Exercise | A | 48.85 | 11,000 | 537,350 | 11,000 | |
Jun 14 2018 | MYOK | MyoKardia Inc | YARNO WENDY L | Director | Option Exercise | A | 48.85 | 11,000 | 537,350 | 11,000 | |
Jun 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 120,254 | |
Jun 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 48.60 | 100 | 4,860 | 74,949 | 75 K to 74.9 K (-0.13 %) |
Jun 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 47.63 | 500 | 23,815 | 75,049 | 75.5 K to 75 K (-0.66 %) |
Jun 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 46.75 | 2,400 | 112,189 | 75,549 | 77.9 K to 75.5 K (-3.08 %) |
Jun 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 77,949 | 74.9 K to 77.9 K (+4.00 %) |
Jun 01 2018 | MYOK | MyoKardia Inc | Lee June | See Remarks | Grant | A | 33.15 | 426 | 14,122 | 426 | 0 to 426 |
Jun 01 2018 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Grant | A | 33.15 | 368 | 12,199 | 93,914 | 93.5 K to 93.9 K (+0.39 %) |
May 29 2018 | MYOK | MyoKardia Inc | Sanofi | 10% Owner | Buy | P | 49.00 | 150,000 | 7,350,000 | 4,168,899 | 4 M to 4.2 M (+3.73 %) |
May 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 2,981 | 4,492 | 123,254 | |
May 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 47.95 | 1,300 | 62,335 | 74,949 | 76.2 K to 74.9 K (-1.70 %) |
May 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 47.27 | 1,700 | 80,365 | 76,249 | 77.9 K to 76.2 K (-2.18 %) |
May 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 2,981 | 4,492 | 77,949 | 75 K to 77.9 K (+3.98 %) |
May 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Grant | A | 33.15 | 578 | 19,161 | 74,968 | 74.4 K to 75 K (+0.78 %) |
May 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 2,981 | 4,492 | 123,254 | |
May 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 47.95 | 1,300 | 62,335 | 74,949 | 76.2 K to 74.9 K (-1.70 %) |
May 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 47.27 | 1,700 | 80,365 | 76,249 | 77.9 K to 76.2 K (-2.18 %) |
May 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 2,981 | 4,492 | 77,949 | 75 K to 77.9 K (+3.98 %) |
May 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Grant | A | 33.15 | 578 | 19,161 | 74,968 | 74.4 K to 75 K (+0.78 %) |
May 07 2018 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Sell | S | 48.95 | 1,519 | 74,355 | 60,606 | 62.1 K to 60.6 K (-2.45 %) |
May 07 2018 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Grant | A | 33.15 | 348 | 11,536 | 62,125 | 61.8 K to 62.1 K (+0.56 %) |
Apr 12 2018 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Option Exercise | M | 12.25 | 5,000 | 61,250 | 49,850 | |
Apr 12 2018 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Sell | S | 50.00 | 5,000 | 250,000 | 61,777 | 66.8 K to 61.8 K (-7.49 %) |
Apr 12 2018 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Buy | M | 12.25 | 5,000 | 61,250 | 66,777 | 61.8 K to 66.8 K (+8.09 %) |
Apr 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 126,235 | |
Apr 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 48.44 | 1,225 | 59,338 | 74,390 | 75.6 K to 74.4 K (-1.62 %) |
Apr 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 47.62 | 1,775 | 84,526 | 75,615 | 77.4 K to 75.6 K (-2.29 %) |
Apr 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 77,390 | 74.4 K to 77.4 K (+4.03 %) |
Apr 05 2018 | MYOK | MyoKardia Inc | Harris Taylor C. | Chief Financial Off ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
Apr 05 2018 | MYOK | MyoKardia Inc | Harris Taylor C. | Chief Financial Off ... | Option Exercise | A | 48.50 | 100,000 | 4,850,000 | 100,000 | |
Mar 28 2018 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Option Exercise | M | 9.08 | 164 | 1,489 | 28,748 | |
Mar 28 2018 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Sell | S | 50.95 | 164 | 8,356 | 61,777 | 61.9 K to 61.8 K (-0.26 %) |
Mar 28 2018 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Buy | M | 9.08 | 164 | 1,489 | 61,941 | 61.8 K to 61.9 K (+0.27 %) |
Mar 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 129,235 | |
Mar 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 61.07 | 3,000 | 183,205 | 74,390 | 77.4 K to 74.4 K (-3.88 %) |
Mar 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 77,390 | 74.4 K to 77.4 K (+4.03 %) |
Mar 07 2018 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | J | 0.00 | 2,000,000 | 0 | 885,104 | 2.9 M to 885.1 K (-69.32 %) |
Mar 07 2018 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,000,000 | 0 | 885,104 | 2.9 M to 885.1 K (-69.32 %) |
Feb 28 2018 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Option Exercise | M | 9.08 | 5,102 | 46,326 | 28,912 | |
Feb 28 2018 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Sell | S | 60.00 | 5,102 | 306,120 | 61,777 | 66.9 K to 61.8 K (-7.63 %) |
Feb 28 2018 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Buy | M | 9.08 | 5,102 | 46,326 | 66,879 | 61.8 K to 66.9 K (+8.26 %) |
Feb 28 2018 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Sell | S | 60.00 | 2,300 | 138,000 | 93,546 | 95.8 K to 93.5 K (-2.40 %) |
Feb 28 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 5,000 | 7,534 | 132,235 | |
Feb 28 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 60.00 | 5,000 | 300,000 | 74,390 | 79.4 K to 74.4 K (-6.30 %) |
Feb 28 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 5,000 | 7,534 | 79,390 | 74.4 K to 79.4 K (+6.72 %) |
Feb 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 137,235 | |
Feb 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 52.58 | 200 | 10,515 | 74,390 | 74.6 K to 74.4 K (-0.27 %) |
Feb 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 51.92 | 1,147 | 59,547 | 74,590 | 75.7 K to 74.6 K (-1.51 %) |
Feb 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 50.91 | 699 | 35,587 | 75,737 | 76.4 K to 75.7 K (-0.91 %) |
Feb 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 49.78 | 954 | 47,491 | 76,436 | 77.4 K to 76.4 K (-1.23 %) |
Feb 07 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 77,390 | 74.4 K to 77.4 K (+4.03 %) |
Feb 02 2018 | MYOK | MyoKardia Inc | LADD CYNTHIA J | General Counsel | Option Exercise | A | 54.05 | 120,000 | 6,486,000 | 120,000 | |
Jan 18 2018 | MYOK | MyoKardia Inc | Lee June | See Remarks | Option Exercise | A | 0.00 | 11,000 | 0 | 11,000 | |
Jan 18 2018 | MYOK | MyoKardia Inc | Lee June | See Remarks | Option Exercise | A | 52.00 | 66,400 | 3,452,800 | 66,400 | |
Jan 18 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | A | 0.00 | 30,600 | 0 | 30,600 | |
Jan 18 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | A | 52.00 | 184,100 | 9,573,200 | 184,100 | |
Jan 18 2018 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Option Exercise | A | 0.00 | 5,700 | 0 | 5,700 | |
Jan 18 2018 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Option Exercise | A | 52.00 | 34,000 | 1,768,000 | 34,000 | |
Jan 18 2018 | MYOK | MyoKardia Inc | McDowell Robert Scott | Chief Scientific Of ... | Option Exercise | A | 0.00 | 7,700 | 0 | 7,700 | |
Jan 18 2018 | MYOK | MyoKardia Inc | McDowell Robert Scott | Chief Scientific Of ... | Option Exercise | A | 52.00 | 46,000 | 2,392,000 | 46,000 | |
Jan 18 2018 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Option Exercise | A | 0.00 | 3,500 | 0 | 3,500 | |
Jan 18 2018 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Option Exercise | A | 52.00 | 20,800 | 1,081,600 | 20,800 | |
Jan 18 2018 | MYOK | MyoKardia Inc | Semigran Marc | Chief Medical Offic ... | Option Exercise | A | 0.00 | 5,300 | 0 | 5,300 | |
Jan 18 2018 | MYOK | MyoKardia Inc | Semigran Marc | Chief Medical Offic ... | Option Exercise | A | 52.00 | 31,800 | 1,653,600 | 31,800 | |
Jan 16 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 5,000 | 7,534 | 146,912 | |
Jan 16 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 50.00 | 5,000 | 250,000 | 509,117 | 514.1 K to 509.1 K (-0.97 %) |
Jan 16 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 5,000 | 7,534 | 514,117 | 509.1 K to 514.1 K (+0.98 %) |
Jan 16 2018 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Sell | S | 50.00 | 5,000 | 250,000 | 95,846 | 100.8 K to 95.8 K (-4.96 %) |
Jan 10 2018 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Sell | S | 45.00 | 5,000 | 225,000 | 56,777 | 61.8 K to 56.8 K (-8.09 %) |
Jan 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 151,912 | |
Jan 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 41.70 | 3,000 | 125,103 | 509,117 | 512.1 K to 509.1 K (-0.59 %) |
Jan 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 512,117 | 509.1 K to 512.1 K (+0.59 %) |
Jan 05 2018 | MYOK | MyoKardia Inc | Third Rock Ventures III, L.P. | 10% Owner | Sell | S | 42.00 | 816,326 | 34,285,774 | 680,272 | 1.5 M to 680.3 K (-54.55 %) |
Jan 05 2018 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 42.00 | 816,326 | 34,285,774 | 680,272 | 1.5 M to 680.3 K (-54.55 %) |
Jan 03 2018 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Sell | S | 43.38 | 1,100 | 47,715 | 61,777 | 62.9 K to 61.8 K (-1.75 %) |
Jan 03 2018 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Sell | S | 42.76 | 3,900 | 166,751 | 62,877 | 66.8 K to 62.9 K (-5.84 %) |
Dec 26 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 154,912 | |
Dec 26 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 41.09 | 3,000 | 123,268 | 509,117 | 512.1 K to 509.1 K (-0.59 %) |
Dec 26 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 512,117 | 509.1 K to 512.1 K (+0.59 %) |
Dec 08 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | J | 0.00 | 2,000,000 | 0 | 2,885,104 | 4.9 M to 2.9 M (-40.94 %) |
Dec 08 2017 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,000,000 | 0 | 2,885,104 | 4.9 M to 2.9 M (-40.94 %) |
Nov 08 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 4,300 | 6,479 | 157,912 | |
Nov 08 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 40.18 | 1,100 | 44,200 | 509,117 | 510.2 K to 509.1 K (-0.22 %) |
Nov 08 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 40.25 | 3,200 | 128,790 | 510,217 | 513.4 K to 510.2 K (-0.62 %) |
Nov 08 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 4,300 | 6,479 | 513,417 | 509.1 K to 513.4 K (+0.84 %) |
Nov 03 2017 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Grant | A | 11.56 | 1,128 | 13,040 | 100,846 | 99.7 K to 100.8 K (+1.13 %) |
Nov 03 2017 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Grant | A | 11.56 | 1,232 | 14,242 | 66,777 | 65.5 K to 66.8 K (+1.88 %) |
Nov 03 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Grant | A | 11.56 | 954 | 11,028 | 509,117 | 508.2 K to 509.1 K (+0.19 %) |
Oct 06 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 4,300 | 6,479 | 162,212 | |
Oct 06 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 40.86 | 4,300 | 175,699 | 508,163 | 512.5 K to 508.2 K (-0.84 %) |
Oct 06 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 4,300 | 6,479 | 512,463 | 508.2 K to 512.5 K (+0.85 %) |
Oct 04 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 40.28 | 75,313 | 3,033,578 | 70,763 | 146.1 K to 70.8 K (-51.56 %) |
Sep 29 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | J | 0.00 | 2,000,000 | 0 | 4,885,104 | 6.9 M to 4.9 M (-29.05 %) |
Sep 29 2017 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,000,000 | 0 | 4,885,104 | 6.9 M to 4.9 M (-29.05 %) |
Sep 27 2017 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 43.00 | 400,000 | 17,200,000 | 6,885,104 | 7.3 M to 6.9 M (-5.49 %) |
Sep 27 2017 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 43.00 | 201,400 | 8,660,200 | 7,285,104 | 7.5 M to 7.3 M (-2.69 %) |
Sep 27 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 43.00 | 400,000 | 17,200,000 | 6,885,104 | 7.3 M to 6.9 M (-5.49 %) |
Sep 27 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 43.00 | 201,400 | 8,660,200 | 7,285,104 | 7.5 M to 7.3 M (-2.69 %) |
Sep 12 2017 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 44.25 | 20,000 | 885,080 | 57,651 | 77.7 K to 57.7 K (-25.76 %) |
Sep 12 2017 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 42.39 | 900 | 38,149 | 7,486,504 | 7.5 M to 7.5 M (-0.01 %) |
Sep 12 2017 | MYOK | MyoKardia Inc | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 41.00 | 200,350 | 8,214,350 | 7,487,404 | 7.7 M to 7.5 M (-2.61 %) |
Sep 12 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 42.39 | 900 | 38,149 | 7,486,504 | 7.5 M to 7.5 M (-0.01 %) |
Sep 12 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Sell | S | 41.00 | 200,350 | 8,214,350 | 7,487,404 | 7.7 M to 7.5 M (-2.61 %) |
Sep 07 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 4,300 | 6,479 | 166,512 | |
Sep 07 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 43.67 | 300 | 13,102 | 508,163 | 508.5 K to 508.2 K (-0.06 %) |
Sep 07 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 42.98 | 4,000 | 171,902 | 508,463 | 512.5 K to 508.5 K (-0.78 %) |
Sep 07 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 4,300 | 6,479 | 512,463 | 508.2 K to 512.5 K (+0.85 %) |
Aug 24 2017 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Sell | S | 45.00 | 5,000 | 225,000 | 99,718 | 104.7 K to 99.7 K (-4.77 %) |
Aug 16 2017 | MYOK | MyoKardia Inc | YARNO WENDY L | Director | Buy | P | 35.50 | 1,408 | 49,984 | 1,408 | 0 to 1.4 K |
Aug 16 2017 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Sell | S | 40.00 | 5,000 | 200,000 | 104,718 | 109.7 K to 104.7 K (-4.56 %) |
Aug 16 2017 | MYOK | MyoKardia Inc | Sanofi | 10% Owner | Buy | P | 35.50 | 350,000 | 12,425,000 | 4,018,899 | 3.7 M to 4 M (+9.54 %) |
Aug 09 2017 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Sell | S | 35.00 | 5,000 | 175,000 | 109,718 | 114.7 K to 109.7 K (-4.36 %) |
Aug 09 2017 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Sell | S | 30.00 | 5,000 | 150,000 | 114,718 | 119.7 K to 114.7 K (-4.18 %) |
Aug 09 2017 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Sell | S | 25.00 | 5,000 | 125,000 | 119,718 | 124.7 K to 119.7 K (-4.01 %) |
Aug 09 2017 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Sell | S | 30.00 | 10,000 | 300,000 | 65,545 | 75.5 K to 65.5 K (-13.24 %) |
Aug 09 2017 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Sell | S | 25.00 | 5,000 | 125,000 | 75,545 | 80.5 K to 75.5 K (-6.21 %) |
Aug 04 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 4,300 | 6,479 | 170,812 | |
Aug 04 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 16.62 | 4,300 | 71,465 | 508,163 | 512.5 K to 508.2 K (-0.84 %) |
Aug 04 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 4,300 | 6,479 | 512,463 | 508.2 K to 512.5 K (+0.85 %) |
Jul 27 2017 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Sell | S | 15.02 | 4,333 | 65,060 | 80,545 | 84.9 K to 80.5 K (-5.10 %) |
Jul 27 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 31,850 | 48,094 | 175,112 | |
Jul 27 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 15.00 | 32,988 | 494,902 | 508,163 | 541.2 K to 508.2 K (-6.10 %) |
Jul 27 2017 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 31,850 | 48,094 | 541,151 | 509.3 K to 541.2 K (+6.25 %) |
Jul 24 2017 | MYOK | MyoKardia Inc | McDowell Robert Scott | See Remarks | Option Exercise | A | 13.90 | 20,000 | 278,000 | 20,000 | |
Jul 24 2017 | MYOK | MyoKardia Inc | Bauer Jake | See Remarks | Option Exercise | A | 13.90 | 15,000 | 208,500 | 15,000 | |
Jun 16 2017 | MYOK | MyoKardia Inc | Meeker David P | Director | Option Exercise | A | 14.00 | 11,000 | 154,000 | 11,000 | |
Jun 16 2017 | MYOK | MyoKardia Inc | CRANSTON MARY B | Director | Option Exercise | A | 14.00 | 11,000 | 154,000 | 11,000 | |
Jun 16 2017 | MYOK | MyoKardia Inc | STARR KEVIN P | Director | Option Exercise | A | 14.00 | 11,000 | 154,000 | 11,000 |